SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405:
SEC Accession No. 0001437749-24-010500
Filing Date
2024-04-02
Accepted
2024-04-02 08:00:17
Documents
1
Period of Report
2023-12-31
Effectiveness Date
2024-04-02

Document Format Files

Seq Description Document Type Size
1 FORM NT 10-K rvph20240401_nt10k.htm NT 10-K 27936
  Complete submission text file 0001437749-24-010500.txt   29161
Mailing Address 10080 N WOLFE ROAD SUITE SW3-200 CUPERTINO CA 95014
Business Address 10080 N WOLFE ROAD SUITE SW3-200 CUPERTINO CA 95014 4085018881
REVIVA PHARMACEUTICALS HOLDINGS, INC. (Filer) CIK: 0001742927 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: NT 10-K | Act: 34 | File No.: 001-38634 | Film No.: 24812264
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)